Target Name: MIP
NCBI ID: G4284
Review Report on MIP Target / Biomarker Content of Review Report on MIP Target / Biomarker
MIP
Other Name(s): AQP-0 | CTRCT15 | MP26 | MIP_HUMAN | aquaporin 0 | Aquaporin 0 | AQP0 | Lens fiber major intrinsic protein | Aquaporin-0 | major intrinsic protein of lens fiber | Major intrinsic protein of lens fiber | MIP26 | LIM1

MIP: A Protein That Interacts with AQP-0 Operator

MIP (Mesothelin-Incorporated Polymorphin) is a protein that is expressed in various tissues throughout the body, including the skin, bone, and soft tissues. It is a type of transmembrane protein that is characterized by its ability to interact with and incorporate the polymerase chain reaction (PCR) operator, also known as AQP-0.

The AQP-0 operator is a viral gene that is found in many human cancers, including breast, ovarian, and prostate cancers. It has been shown to promote the growth and survival of cancer cells, and is involved in the development of drug resistance.

MIP is also known as \"Mesothelin-Incorporated Polymorphin,\" because it is embedded within the cell membrane and is involved in the formation of the cell membrane. It is a type of cytoplasmic protein that is composed of four transmembrane domains: a N-terminus, a T-terminus, a middle intermembrane region, and a C-terminus.

MIP is a protein that is expressed in many different tissues throughout the body, including the skin, bone, and soft tissues. It is a type of transmembrane protein that is characterized by its ability to interact with and incorporate the AQP-0 operator, also known as the polymerase chain reaction (PCR) operator.

The AQP-0 operator is a viral gene that is found in many human cancers, including breast, ovarian, and prostate cancers. It has been shown to promote the growth and survival of cancer cells and is involved in the development of drug resistance.

MIP is also known as \"Mesothelin-Incorporated Polymorphin,\" because it is embedded within the cell membrane and is involved in the formation of the cell membrane. It is a type of cytoplasmic protein that is composed of four transmembrane domains: a N-terminus, a T-terminus, a middle intermembrane region, and a C-terminus.

MIP is expressed in many different tissues throughout the body, including the skin, bone, and soft tissues. It is a type of transmembrane protein that is characterized by its ability to interact with and incorporate the AQP-0 operator, also known as the PCR operator.

The AQP-0 operator is a viral gene that is found in many human cancers, including breast, ovarian, and prostate cancers. It has been shown to promote the growth and survival of cancer cells and is involved in the development of drug resistance.

MIP is also known as \"Mesothelin-Incorporated Polymorphin,\" because it is embedded within the cell membrane and is involved in the formation of the cell membrane. It is a type of cytoplasmic protein that is composed of four transmembrane domains: a N-terminus, a T-terminus, a middle intermembrane region, and a C-terminus.

MIP is a protein that is expressed in various tissues throughout the body, including the skin, bone, and soft tissues. It is a type of transmembrane protein that is characterized by its ability to interact with and incorporate the AQP-0 operator, also known as the PCR operator.

The AQP-0 operator is a viral gene that is found in many human cancers, including breast, ovarian, and prostate cancers. It has been shown to promote the growth and survival of cancer cells and is involved in the development of drug resistance.

MIP is also known as \"Mesothelin-Incorporated Polymorphin,\" because it is embedded within the cell membrane and is involved in the formation of the cell membrane. It is a type of cytoplasmic protein that is composed of four transmembrane domains: a N-terminus, a T-terminus, a middle intermembrane region, and a C-terminus.

Despite the fact that MIP is a protein that is expressed in many different tissues throughout the body, it has not yet been shown to have any biological function or to be involved in any specific diseases. However, the AQP-0 operator is a viral gene that is found in many human cancers, including breast, ovarian, and prostate cancers. It has been shown to promote the growth and survival of cancer cells and is involved in the development of drug resistance.

MIP is also known as \"Mesothelin-Incorporated Polymorphin,\" because it is embedded within the cell membrane and is involved in the formation of the cell membrane. It is a type of cytoplasmic protein that is composed of four transmembrane domains: a N-terminus, a T-terminus, a middle intermembrane region, and a C-terminus.

In conclusion, MIP is a protein that is expressed in various tissues throughout the body, including the skin, bone, and soft tissues. It is a type of transmembrane protein that is characterized by its ability to interact with and incorporate the AQP-0 operator, also known as the PCR operator. The AQP-0 operator is a viral gene that is found in many human cancers, including breast, ovarian, and prostate cancers. It has been shown to promote the growth and survival of cancer cells and is involved in the development of drug resistance. Despite the fact that MIP is a protein that is expressed in many different tissues throughout the body, it has not yet been shown to have any biological function or to be involved in any specific diseases.

Protein Name: Major Intrinsic Protein Of Lens Fiber

Functions: Water channel (PubMed:24120416). Channel activity is down-regulated by CALM when cytoplasmic Ca(2+) levels are increased. May be responsible for regulating the osmolarity of the lens. Interactions between homotetramers from adjoining membranes may stabilize cell junctions in the eye lens core (By similarity). Plays a role in cell-to-cell adhesion and facilitates gap junction coupling (PubMed:24120416)

The "MIP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIPEP | MIPEPP3 | MIPOL1 | MIR1-1 | MIR1-1HG | MIR1-2 | MIR100 | MIR100HG | MIR101-1 | MIR101-2 | MIR10394 | MIR10396B | MIR10399 | MIR103A1 | MIR103A2 | MIR103B1 | MIR103B2 | MIR105-1 | MIR105-2 | MIR10527 | MIR106A | MIR106B | MIR107 | MIR10A | MIR10B | MIR11181 | MIR11400 | MIR11401 | MIR1178 | MIR1179 | MIR1180 | MIR1181 | MIR1182 | MIR1183 | MIR1184-1 | MIR1184-2 | MIR1184-3 | MIR1185-1 | MIR1185-2 | MIR1193 | MIR1197 | MIR1199 | MIR1200 | MIR1202 | MIR1203 | MIR1204 | MIR1205 | MIR1206 | MIR1207 | MIR1208 | MIR12129 | MIR12135 | MIR12136 | MIR122 | MIR1224 | MIR1225 | MIR1226 | MIR1227 | MIR1228 | MIR1229 | MIR1231 | MIR1233-1 | MIR1233-2 | MIR1234 | MIR1236 | MIR1237 | MIR1238 | MIR124-1 | MIR124-1HG | MIR124-2 | MIR124-2HG | MIR124-3 | MIR1243 | MIR1244-1 | MIR1244-2 | MIR1244-3 | MIR1245A | MIR1245B | MIR1246 | MIR1247 | MIR1248 | MIR1249 | MIR1250 | MIR1251 | MIR1252 | MIR1253 | MIR1254 | MIR1255A | MIR1255B1 | MIR1255B2 | MIR1256 | MIR1257 | MIR1258 | MIR125A | MIR125B1 | MIR125B2 | MIR126 | MIR1260A | MIR1260B | MIR1261